You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

SYNAREL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Synarel, and what generic alternatives are available?

Synarel is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in SYNAREL is nafarelin acetate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the nafarelin acetate profile page.

Drug patent expirations by year for SYNAREL
Drug Prices for SYNAREL

See drug prices for SYNAREL

Recent Clinical Trials for SYNAREL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, San DiegoEarly Phase 1
Shaare Zedek Medical CenterN/A
New Hope Fertility CenterN/A

See all SYNAREL clinical trials

US Patents and Regulatory Information for SYNAREL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer SYNAREL nafarelin acetate SPRAY, METERED;NASAL 019886-001 Feb 13, 1990 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for SYNAREL

See the table below for patents covering SYNAREL around the world.

Country Patent Number Title Estimated Expiration
Hungary 185379 PROCESS FOR THE PRODUCTION OF THE NONAPEPTIDE AND DECAPEPTIDE DERIVATIVES OF THE LUTEOTROPE RELEASING FACTOR ⤷  Try a Trial
United Kingdom 2054603 NONAPEPTIDE AND DECAPEPTIDE DERIVATIVES OF LUTEINIZING HORMONE RELEASING HORMONE ⤷  Try a Trial
Norway 801729 ⤷  Try a Trial
Greece 69259 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for SYNAREL

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0021234 93C0049 Belgium ⤷  Try a Trial PRODUCT NAME: NAFARELIN. ACETAT; NAT. REG.: 194 IS 46 F 11 19920616; FIRST REG.: DK D.SP.NR. 8291 19900628
0021234 SPC/GB93/056 United Kingdom ⤷  Try a Trial SPC/GB93/056, EXPIRES: 20050609
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.